PARIS (AP) -- French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion, ending months of corporate haggling....
genzyme corpSanofi-Aventis to buy Genzyme for $20.1 bln cashHeadlines from the Associated Press Wed, 02/16/2011 - 03:45
Genzyme SettlesHealth Care Renewal Tue, 05/25/2010 - 15:42
In late 2009, we posted about problems at a Genzyme plant that manufactured some fabulously expensive drugs, e.g. Tags:
Genzyme's "Remarkable Business'Strategy" and Contaminated DrugsHealth Care Renewal Wed, 11/18/2009 - 15:42
In June, 2009, an article in the Boston Globe described how the Boston area based biotechnology company Genzyme sold some astonishlingly expensive drugs, using |
